The Types axis of market taxonomy classifies conical implants by material composition and surface engineering, primarily into Titanium, Zirconia, and Polyetheretherketone (PEEK) families. Titanium implants dominate, representing roughly 75 % of unit sales, with sub‑categories of commercially pure (CP‑Ti) and Ti‑6Al‑4V alloy. Within titanium, surface‑treated variants—hydroxyapatite‑coated, anodized, and laser‑textured—capture an additional 20 % premium share by enhancing osseointegration and reducing healing time. Zirconia implants, accounting for about 15 % of the market, offer ceramic aesthetics and high biocompatibility, appealing to patients with metal sensitivities; however, their brittleness limits high‑load applications, constraining growth. PEEK devices, still emerging at roughly 10 %, exploit a modulus closer to cortical bone, reducing stress shielding, and are gaining traction in spinal and craniofacial niches where radiolucency is advantageous. Each material’s share reflects a balance of clinical performance, cost structure, and regulatory acceptance, collectively defining the overall Conical Implant market size. Thus, material selection drives pricing strategy and influences long‑term market penetration across clinical specialties.
